Innospec 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Innospec reported 3rd quarter 2026 revenue of $473.6 million, up 7% from $441.9 million a year ago, and gross margin of 27.3%, an increase of 0.9 percentage points from last year.
- Adjusted EBITDA was $51.4 million compared to $44.2 million last year, net income attributable to Innospec was $31.8 million compared to $12.9 million a year ago, and adjusted EPS was $1.29 compared to $1.12 a year ago.
- Performance Chemicals revenue was $180.5 million, up 6%; gross margin was 18.8%, up 3.7 percentage points; and operating income was $16.9 million, up 84% from $9.2 million last year.
- Fuel Specialties revenue was $180.7 million, up 5%, with volumes up 3% and price mix up 2%; gross margin was 31.5% and operating income was $35.6 million, up 1% from $35.3 million a year ago.
- Oilfield Services revenue was $112.4 million, up 13%; gross margin was 28.2%, down 1.8 percentage points from last year's 30% on a weaker sales mix; and operating income was $6.7 million, up 40% from $4.8 million a year ago.
- Corporate costs were $18.6 million compared with $18.2 million a year ago, and the adjusted effective tax rate was 24.7% compared to 22.7% last year.
- Cash from operating activities was $17.4 million before capital expenditures of $15.6 million; as of September 30th, Innospec had $251.9 million in cash and cash equivalents and no debt.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Good day, and thank you for standing by. Welcome to Innospec's third quarter 2026 earnings release and conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star, one, and one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star, one, and one again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, David Jones, General Counsel and Chief Compliance Officer. Please go ahead. Thank you.
Welcome to Innospec's quarterly earnings call. This is David Jones, and I'm Innospec's General Counsel and Chief Compliance Officer. The earnings release for the quarter and this presentation are posted on the company's website. During this call, we will make forward-looking statements, which are predictions and projections about future events. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from the anticipated results implied by such forward-looking statements. The risks and uncertainties are detailed in Innospec's filings with the SEC. Please see the SEC site and Innospec's site for these and related documents. In today's presentation, we've also included non-GAAP financial measures. A reconciliation to the most directly comparable GAAP financial measure is contained in the earnings release.
The non-GAAP financial measures should not be considered as a substitute for those prepared in accordance with GAAP. They are included as additional items to aid investor understanding of the company's performance and the additional impact that these items and events had on financial results. With me today from Innospec are Patrick Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer. With that, I turn it over to you, Patrick.
Thank you, David, and welcome everyone to Innospec's third quarter 2026 conference call. This was a strong quarter for Innospec, with all businesses delivering sales growth and operating income improvement. Performance Chemicals sales growth and gross margin improvement drove an 84% operating income increase over last year. The North Carolina plant efficiency upgrades discussed last quarter are scheduled to be completed by year-end. These upgrades will increase capacity, productivity, and yield on a wide range of existing personal care and other products. In parallel, we will continue to focus on commercializing new products to drive further margin and operating income improvement in the coming quarters. Fuel Specialties had another strong quarter, delivering revenue and operating income growth with margins in our target range. Both volume and price mix improved as the business has continued to manage well against raw material volatility.
We expect continued strong performance and seasonal demand in the coming quarters. Oilfield Services operating income grew 40%, and operating margins expanded, driven by improved volumes from our recent DRA plant expansion. Third quarter results were lower than expected on activity delays in our Middle East legacy business, along with elevated raw material costs. We expect sequential improvement in the fourth quarter. Now I will turn the call over to Ian Cleminson, who will review our financial results in more detail. Then I will return with some concluding comments. After that, Ian and I will take your questions.
Ian? Thanks, Patrick. Turning to slide seven in the presentation, the company's total revenues for the third quarter were $473.6 million, a 7% increase from $441.9 million a year ago.
Overall gross margin increased by 0.9 percentage points from last year to 27.3%. Adjusted EBITDA for the quarter was $51.4 million compared to $44.2 million last year, and net income attributable to Innospec for the quarter was $31.8 million compared to $12.9 million a year ago. Our GAAP earnings per share were $1.29, and there was no net impact of special items in the quarter. Last year, we reported GAAP earnings per share of $0.52, which included a negative impact from special items of $0.60 per share. Excluding special items in both years, our adjusted EPS for the quarter was $1.29 compared to $1.12 a year ago.
Turning to slide eight, revenues in Performance Chemicals for the third quarter were $180.5 million, up 6% from last year's $170.8 million. Volume reductions of 5% and a negative currency impact of 1% were offset by a positive price mix of 12%, driven by higher raw material pricing. Gross margins of 18.8% increased 3.7 percentage points compared to 15.1% in the same quarter in 2025. Operating income of $16.9 million increased 84% from $9.2 million last year. We expect the fourth quarter results to be similar to this quarter, with the plant upgrades in North Carolina the key to unlocking growth in 2027. Moving on to slide nine, revenues in Fuel Specialties for the third quarter were $180.7 million, up 5% from $172 million reported a year ago. Volumes were up 3%, with price mix up 2%.
Fuel Specialties gross margins of 31.5% decreased half a percentage point compared to 35.6% in the same quarter last year. Operating income of $35.6 million was up 1% from $35.3 million a year ago. Moving on to slide 10. Revenues in Oilfield Services for the quarter were $112.4 million, up 13% from the $99.1 million reported a year ago. Gross margins of 28.2% decreased 1.8 percentage points from last year's 30% on a weaker sales mix. Operating income of $6.7 million increased 40% from $4.8 million one year ago. Turning to slide 11. Corporate costs for the quarter were $18.6 million compared with $18.2 million a year ago. The adjusted effective tax rate for the quarter was 24.7% compared to 22.7% last year. Moving on to slide 12. Cash from operating activities was $17.4 million before capital expenditures of $15.6 million.
As of September the 30th, Innospec had $251.9 million in cash and cash equivalents and no debt. Now I'll turn it back over to Patrick for some final comments.
Patrick? Thanks, Ian. Again this quarter, Innospec delivered strong sales and operating income growth with higher margins.
Performance Chemicals and Oilfield Services remain our key focus. We expect continued steady and strong results in Fuel Specialties. Operating cash generation was positive in the quarter, and our net cash position remained at over $250 million. We continue to focus on driving increased operating cash flow in the coming quarters with better working and capital efficiency. We have significant balance sheet flexibility for organic investment, M&A, dividend growth, and buybacks. This quarter, our board approved a further increase in our semi-annual dividend to $0.94 per share, resulting in an annual dividend increase of 9%. Now I will turn the call over to the operator, and Ian and I will take your questions.
Thank you. To ask a question, you will need to press star, one, and one on your telephone and wait for your name to be announced. To withdraw your question, please press star, one, and one again. We are now going to take our first question, and this one comes from Jon Tanwanteng from CJS Securities. Please go ahead. Hi, good morning.
Thank you for taking my questions. I was wondering- Yeah, Jon.
If you could quantify Good morning. I was wondering if you could quantify the impact in the Oilfield Services business from delays in the Mideast, and I'm assuming that that was pipeline attacks in Saudi, number one, in the quarter. And number two, how you expect that business to trend in Q4, assuming a recovery there and the underlying inflation dynamics?
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
6 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
